MARZOLA, Giuliano
 Distribuzione geografica
Continente #
NA - Nord America 1.628
EU - Europa 335
AS - Asia 254
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 1
Totale 2.220
Nazione #
US - Stati Uniti d'America 1.614
CN - Cina 163
UA - Ucraina 102
DE - Germania 73
TR - Turchia 56
GB - Regno Unito 53
IT - Italia 47
SG - Singapore 27
FI - Finlandia 26
SE - Svezia 20
CA - Canada 14
FR - Francia 5
CZ - Repubblica Ceca 3
IR - Iran 3
RU - Federazione Russa 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BE - Belgio 2
HK - Hong Kong 2
IN - India 2
BD - Bangladesh 1
CL - Cile 1
PL - Polonia 1
Totale 2.220
Città #
Fairfield 226
Woodbridge 214
Houston 168
Ashburn 130
Jacksonville 117
Chandler 95
Ann Arbor 94
Seattle 86
Wilmington 84
Cambridge 78
Beijing 52
Nanjing 34
Izmir 29
New York 28
Boardman 25
San Diego 25
Princeton 23
Shanghai 23
Milan 19
Munich 17
Ferrara 16
Mcallen 13
Montréal 12
Singapore 12
Bremen 11
Dearborn 9
Hebei 8
Nanchang 8
Shenyang 8
Falls Church 6
Addison 5
Changsha 5
Helsinki 5
Mountain View 5
Norwalk 5
San Mateo 5
Tappahannock 5
Tianjin 5
Washington 5
Indiana 4
Jiaxing 4
Philadelphia 4
Ardabil 3
Auburn Hills 3
Los Angeles 3
Olomouc 3
Brussels 2
Ferrara di Monte Baldo 2
Hong Kong 2
Jinan 2
Kunming 2
Lanzhou 2
Leawood 2
Ningbo 2
Redwood City 2
San Francisco 2
Verona 2
Zhengzhou 2
Changchun 1
Chicago 1
Chongqing 1
Dhaka 1
Guangzhou 1
Hangzhou 1
Hounslow 1
Kilburn 1
La Canada Flintridge 1
Las Vegas 1
Markham 1
Oklahoma City 1
Orange 1
Redmond 1
Taizhou 1
Toronto 1
Warsaw 1
Yellow Springs 1
Totale 1.781
Nome #
[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor 157
[Dmt(1) ]N/OFQ(1-13)-NH(2) , a potent nociceptin/orphanin FQ and opioid receptor universal agonist. 135
Behavioural phenotypic characterization of CD-1 mice lacking the neuropeptide S receptor 131
In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor 124
Ascorbic and 6-Br-ascorbic acid conjugates as a tool to increase the therapeutic effects of potentially central active drugs 122
Post-ischemic recovery of acetylcholine release in vitro: influence of different excitatory amino acid receptor subtype antagonists 119
Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test 119
[(t)Bu-d-Gly(5)]NPS, a pure and potent antagonist of the neuropeptide S receptor: In vitro and in vivo studies 116
Endogenous nociceptin/orphanin FQ signalling produces opposite spinal antinociceptive and supraspinal pronociceptive effects in the mouse formalin test: Pharmacological and genetic evidences 113
Anti-inflammatory and analgesic effects displayed by peptides derived from PKI55 protein, an endogenous protein kinase C inhibitor 113
Nociceptin/orphanin FQ receptor knockout rats: in vitro and in vivo studies. 107
Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay 106
[Arg(14), Lys(15)]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studies 104
Further studies on the pharmacological features of the nociceptin/orphanin FQ receptor ligand ZP120 102
The nociceptin/orphanin FQ receptor antagonist, [Nphe(1)]NC(1-13)NH2, potentiates morphine analgesia 100
Characterization of [Nphe(1)]nociceptin(1-13)NH2, a new selective nociceptin receptor antagonist 99
Altered anxiety-related behavior in nociceptin/orphanin FQ receptor gene knockout mice 96
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8 ,9-tetrahydro-5H-benzocyclohepten-5-ol]: In vivo studies 75
Neuropeptide S is a stimulatory anxiolytic agent: A behavioural study in mice 73
In vitro and in vivo pharmacological characterization of the neuropeptide S receptor antagonist [D-Cys(tBu)5]NPS. 64
null 50
Pharmacological characterisation of [(pX)Phe4]nociceptin(1-13)NH2 analogues 2. In vivo studies 16
Totale 2.241
Categoria #
all - tutte 8.792
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.792


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020560 73 22 16 79 39 57 47 60 48 56 46 17
2020/2021288 31 32 16 31 21 32 3 34 6 31 38 13
2021/2022281 6 31 33 17 18 13 12 20 9 26 25 71
2022/2023232 21 18 21 31 37 26 17 14 27 1 9 10
2023/2024183 14 15 11 7 9 58 8 13 4 1 8 35
2024/20253 3 0 0 0 0 0 0 0 0 0 0 0
Totale 2.241